Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31000589)

  • 1. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.
    Yun EJ; Lin CJ; Dang A; Hernandez E; Guo J; Chen WM; Allison J; Kim N; Kapur P; Brugarolas J; Wu K; He D; Lai CH; Lin H; Saha D; Baek ST; Chen BPC; Hsieh JT
    Clin Cancer Res; 2019 Jul; 25(14):4542-4551. PubMed ID: 31000589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation.
    Zhang X; Wang Q; Zhang R; Kong Z
    Int J Radiat Biol; 2023; 99(10):1595-1606. PubMed ID: 36947637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.
    Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D
    Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
    Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ‑rays and α‑particles in prostate cancer cells.
    Yang C; He H; Zhang T; Chen Y; Kong Z
    Mol Med Rep; 2016 Jul; 14(1):567-73. PubMed ID: 27177018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.
    Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z
    Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
    Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
    Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
    Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
    Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
    Zhou J; Luo J; Wu K; Yun EJ; Kapur P; Pong RC; Du Y; Wang B; Authement C; Hernandez E; Yang J; Xiao G; Cha TL; Wu HC; Wu D; Margulis V; Lotan Y; Brugarolas J; He D; Hsieh JT
    Oncogene; 2016 Sep; 35(35):4663-74. PubMed ID: 26876207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells.
    Chang R; He H; Mao G; Kong Z
    Int J Radiat Biol; 2017 Apr; 93(4):386-393. PubMed ID: 27834104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAB2IP stabilizes p27
    Zhou J; Deng Z; Pei X; Lai J; Qu W
    Funct Integr Genomics; 2023 Oct; 23(4):326. PubMed ID: 37880458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.
    Yu L; Tumati V; Tseng SF; Hsu FM; Kim DN; Hong D; Hsieh JT; Jacobs C; Kapur P; Saha D
    Neoplasia; 2012 Dec; 14(12):1203-12. PubMed ID: 23308052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
    Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
    Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway.
    He H; Chang R; Zhang T; Yang C; Kong Z
    Mol Med Rep; 2017 Aug; 16(2):1216-1222. PubMed ID: 28586028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
    Wan P; Chen Z; Zhong W; Jiang H; Huang Z; Peng D; He Q; Chen N
    Oncol Rep; 2020 Dec; 44(6):2475-2486. PubMed ID: 33125143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
    Chabanon RM; Morel D; Eychenne T; Colmet-Daage L; Bajrami I; Dorvault N; Garrido M; Meisenberg C; Lamb A; Ngo C; Hopkins SR; Roumeliotis TI; Jouny S; Hénon C; Kawai-Kawachi A; Astier C; Konde A; Del Nery E; Massard C; Pettitt SJ; Margueron R; Choudhary JS; Almouzni G; Soria JC; Deutsch E; Downs JA; Lord CJ; Postel-Vinay S
    Cancer Res; 2021 Jun; 81(11):2888-2902. PubMed ID: 33888468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
    Xiong Z; Yuan C; Shi J; Xiong W; Huang Y; Xiao W; Yang H; Chen K; Zhang X
    Theranostics; 2020; 10(25):11444-11461. PubMed ID: 33052225
    [No Abstract]   [Full Text] [Related]  

  • 19. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
    Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
    Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.